Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR
JACC: Cardiovascular Interventions · 2023-02 · 16 (4) · 396-411
DOI: 10.1016/j.jcin.2022.12.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2023-02. Verfasst von Tullio Palmerini und 59 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Cardiac, Thoracic and …. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Ischemic Attack, Transient, Peripheral Arterial Disease, Stroke. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Ludwig-Maximilians-Universität München.
Abstract (Originalsprache)
BACKGROUND: The optimal access route in patients with severe peripheral artery disease (PAD) undergoing transcatheter aortic valve replacement (TAVR) remains undetermined. OBJECTIVES: This study sought to compare clinical outcomes with transfemoral access (TFA), transthoracic access (TTA), and nonthoracic transalternative access (TAA) in TAVR patients with severe PAD. METHODS: Patients with PAD and hostile femoral access (TFA impossible, or possible only after percutaneous treatment) undergoing TAVR at 28 international centers were included in this registry. The primary endpoint was the propensity-adjusted risk of 30-day major adverse events (MAE) defined as the composite of all-cause mortality, stroke/transient ischemic attack (TIA), or main access site-related Valve Academic Research Consortium 3 major vascular complications. Outcomes were also stratified according to the severity of PAD using a novel risk score (Hostile score). RESULTS: Among the 1,707 patients included in the registry, 518 (30.3%) underwent TAVR with TFA after percutaneous treatment, 642 (37.6%) with TTA, and 547 (32.0%) with TAA (mostly transaxillary). Compared with TTA, both TFA (adjusted HR: 0.58; 95% CI: 0.45-0.75) and TAA (adjusted HR: 0.60; 95% CI: 0.47-0.78) were associated with lower 30-day rates of MAE, driven by fewer access site-related complications. Composite risks at 1 year were also lower with TFA and TAA compared with TTA. TFA compared with TAA was associated with lower 1-year risk of stroke/TIA (adjusted HR: 0.49; 95% CI: 0.24-0.98), a finding confined to patients with low Hostile scores (Pinteraction = 0.049). CONCLUSIONS: Among patients with PAD undergoing TAVR, both TFA and TAA were associated with lower 30-day and 1-year rates of MAE compared with TTA, but 1-year stroke/TIA rates were higher with TAA compared with TFA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Cardiac, Thoracic and Vascular Department, Università di Bologna, Bologna, Italy. Electronic…
- Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Cardiac, Thoracic and Vascular Department, Università di Bologna, Bologna, Italy.
- Kerckhoff Heart Center, Bad Nauheim, Germany.
- UOSA Cardiologia Interventistica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
- Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- U.O.C. di Interventistica Cardiologica e Diagnostica Invasiva, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Förderung
- Ludwig-Maximilians-Universität München
Zitieren
APA
Palmerini, T., Saia, F., Kim, W. K., Renker, M., Iadanza, A., Fineschi, M., Bruno, A. G., Ghetti, G., Vanhaverbeke, M., Søndergaard, L., De Backer, O., Romagnoli, E., Burzotta, F., Trani, C., Adrichem, R., Van Mieghem, N. M., Nardi, E., Chietera, F., Orzalkiewicz, M., …, & Scotti, A. (2023). Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR. JACC: Cardiovascular Interventions, 16(4), 396-411. https://doi.org/10.1016/j.jcin.2022.12.009
Vancouver
Palmerini T, Saia F, Kim WK, Renker M, Iadanza A, Fineschi M, et al. Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR. JACC: Cardiovascular Interventions. 2023;16(4):396-411. doi:10.1016/j.jcin.2022.12.009
BibTeX
@article{Palmerini2023,
author = {Palmerini, Tullio and Saia, Francesco and Kim, Won-Keun and Renker, Matthias and Iadanza, Alessandro and Fineschi, Massimo and Bruno, Antonio Giulio and Ghetti, Gabriele and Vanhaverbeke, Maarten and Søndergaard, Lars and De Backer, Ole and Romagnoli, Enrico and Burzotta, Francesco and Trani, Carlo and Adrichem, Rik and Van Mieghem, Nicolas M and Nardi, Elena and Chietera, Francesco and Orzalkiewicz, Mateusz and Tomii, Daijiro and Pilgrim, Thomas and Aranzulla, Tiziana Claudia and Musumeci, Giuseppe and Adam, Matti and Meertens, Max M and Taglieri, Nevio and Marrozzini, Cinzia and Alvarez Covarrubias, Hector Alfonso and Joner, Michael and Nardi, Giulia and Di Muro, Francesca Maria and Di Mario, Carlo and Loretz, Lucca and Toggweiler, Stefan and Gallitto, Enrico and Gargiulo, Mauro and Testa, Luca and Bedogni, Francesco and Berti, Sergio and Ancona, Marco B and Montorfano, Matteo and Leone, Alessandro and Savini, Carlo and Pacini, Davide and Gmeiner, Jonas and Braun, Daniel and Nerla, Roberto and Castriota, Fausto and De Carlo, Marco and Petronio, Anna Sonia and Barbanti, Marco and Costa, Giuliano and Tamburino, Corrado and Leone, Pier Pasquale and Reimers, Bernhard and Stefanini, Giulio and Sudo, Mitsumasa and Nickenig, Georg and Piva, Tommaso and Scotti, Andrea},
title = {Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR},
journal = {JACC: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {4},
pages = {396--411},
doi = {10.1016/j.jcin.2022.12.009}
}
EUVIMED